Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones

Hickok LR, L R Hickok, Lee R. Hickok, K A Burry, Kenneth A. Burry, Burry KA, N L Cohen, Cohen NL, Nancy L. Cohen, Moore DE, Donald E. Moore, D E Moore, Kristine D. Dahl, Dahl KD, K D Dahl, M R Soules, Michael R. Soules, Soules MR
Fertility and sterility · 1991 · vol. 56(4) , pp. 622–627 · doi:10.1016/s0015-0282(16)54590-7 · PMID:1833245 · W17769259
article OA: closed CC0 ⤵ 9 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study compared the suppressive effects of danazol and nafarelin on reproductive hormones in the medical treatment of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectivePatients with endometriosis were studied to investigate hormonal suppression by the gonadotropin-releasing hormone against nafarelin acetate compared with danazol. We hypothesized that the pattern, time course, and degree of gonadotropin and ovarian suppression would be different.DesignThe study included 16 patients who were randomized into one of three 6-month treatment protocols.SettingPatients were recruited from a university hospital setting.PatientsEligible candidates were 18 to 45 years of age, with regular menses and documented pelvic endometriosis.InterventionSix-month treatment protocols included nafarelin 800 or 400 micrograms/d, or danazol 800 mg/d.Main outcome measuresSerum estradiol (E2), progesterone (P), luteinizing hormone (LH), and follicle-stimulating hormone were determined before treatment and then monthly. Thirteen patients consented to a 12-hour hospital admission during the 5th and 6th month of treatment to determine LH pulse frequency and amplitude.ResultsEstradiol and P were suppressed in all groups, but E2 significantly more by nafarelin than danazol (P less than or equal to 0.01). Nafarelin, 800 micrograms, significantly depressed LH pulse amplitude compared with danazol (P less than or equal to 0.05). Two patients in the nafarelin group had the administration of their medication observed, and both demonstrated single, high-amplitude pulses immediately after administration.ConclusionNafarelin is a more potent LH and E2 suppressor than danazol, and the agonist effect of nafarelin may continue to provoke transient gonadotropin responses despite long-term therapeutic suppression.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Estradiol Gonadotropin-Releasing Hormone Luteinizing Hormone Progesterone Adult Danazol Danazol Endometriosis Endometriosis Estradiol Female Follicle Stimulating Hormone Follicle Stimulating Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Luteinizing Hormone

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

Cited by (9)

Source provenance

europepmc
last seen: 2026-09-20T09:27:46.357103+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:54.876058+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK